statistiche ricercatore

Continente	#
NA - Nord America	934
EU - Europa	474
AS - Asia	390
SA - Sud America	71
AF - Africa	11
Continente sconosciuto - Info sul continente non disponibili	10
OC - Oceania	1
Totale	1.891

Nazione	#
US - Stati Uniti d'America	912
DE - Germania	229
SG - Singapore	142
CN - Cina	135
SE - Svezia	74
BR - Brasile	54
UA - Ucraina	47
FR - Francia	44
VN - Vietnam	32
IT - Italia	18
IN - India	17
IE - Irlanda	16
BD - Bangladesh	10
FI - Finlandia	10
ID - Indonesia	10
JP - Giappone	9
CA - Canada	7
GB - Regno Unito	7
MX - Messico	7
PK - Pakistan	6
EC - Ecuador	5
HK - Hong Kong	5
RU - Federazione Russa	5
AE - Emirati Arabi Uniti	4
BE - Belgio	4
CO - Colombia	4
IQ - Iraq	4
NL - Olanda	4
TR - Turchia	4
ZA - Sudafrica	4
AR - Argentina	3
AT - Austria	3
BB - Barbados	3
KR - Corea	3
CZ - Repubblica Ceca	2
ES - Italia	2
ET - Etiopia	2
JO - Giordania	2
MA - Marocco	2
PL - Polonia	2
PY - Paraguay	2
BG - Bulgaria	1
CH - Svizzera	1
CL - Cile	1
CR - Costa Rica	1
DZ - Algeria	1
FJ - Figi	1
HN - Honduras	1
HR - Croazia	1
IL - Israele	1
IR - Iran	1
IS - Islanda	1
JM - Giamaica	1
KE - Kenya	1
KZ - Kazakistan	1
LA - Repubblica Popolare Democratica del Laos	1
MR - Mauritania	1
NI - Nicaragua	1
NO - Norvegia	1
PR - Porto Rico	1
PS - Palestinian Territory	1
PT - Portogallo	1
SA - Arabia Saudita	1
SK - Slovacchia (Repubblica Slovacca)	1
TH - Thailandia	1
UY - Uruguay	1
VE - Venezuela	1
Totale	1.881

Nome	#
5-azacytidine in chronic myelomonocytic leukemia: case report and review of literature	441
Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia.	204
Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes.	196
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms	192
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms	187
Similarities and differences between therapy-related and elderly acute myeloid leukemia	178
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes	176
PU.1 and CEBPA expression in acute myeloid leukemia.	164
Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine	153
Totale	1.891

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	45	0	0	0	2	5	2	1	13	3	3	8	8
2022/2023	193	18	28	19	37	12	27	9	15	21	1	4	2
2023/2024	80	5	19	4	1	6	22	2	0	0	0	14	7
2024/2025	418	4	4	13	6	16	2	3	14	33	14	287	22
2025/2026	475	76	13	23	40	72	44	73	23	40	45	18	8
2026/2027	61	10	7	36	8	0	0	0	0	0	0	0	0
Totale													1.891

IRIS UniCatt